Suprasellar extension independently predicts preoperative pituitary hormone deficiencies in patients with nonfunctioning pituitary macroadenomas: a single-center experience

被引:5
|
作者
Margaritopoulos, Dimitris [1 ]
Vassiliadi, Dimitra Argyro [1 ]
Markou, Maria [1 ]
Evangelatou, Eirini [1 ]
Tzanela, Marinella [1 ]
Tsagarakis, Stylianos [1 ]
机构
[1] Evangelismos Med Ctr, Dept Endocrinol Diabet & Metab, Athens 10676, Greece
关键词
Nonfunctioning pituitary adenomas; Pituitary hormone deficiencies; Suprasellar extension; Prolactin; HYPOTHALAMIC-PITUITARY; INTRASELLAR PRESSURE; TISSUE PRESSURE; HYPOPITUITARISM; ADENOMAS; HYPERPROLACTINEMIA; CLASSIFICATION; RECOVERY; TUMORS; GLAND;
D O I
10.1007/s42000-020-00183-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Nonfunctioning pituitary adenomas (NFPAs) are among the commonest benign tumors of the pituitary. Hypopituitarism is frequently present at the time of diagnosis, and this has been attributed to stalk portal vessel compression and/or destruction of normal anterior pituitary cells. The aim of our study was to examine possible factors at diagnosis associated with the presence of hypopituitarism. Methods We retrospectively evaluated the records of patients with nonfunctioning pituitary macroadenomas from the database of our department. The inclusion criterion was the availability of imaging data regarding the extension of the lesion. Results A total of 148 patients (89 men, 60.1%) with nonfunctioning macroadenomas and available imaging data were identified. Mean age at diagnosis was 56.0 +/- 14.5 years, and hypopituitarism was found in 66.2%. The maximum diameter of the adenoma, the patient's age at diagnosis, and compression of the optic chiasm were significant factors predicting the presence of hypopituitarism (OR 1.077, p = 0.006; OR 1.025, p = 0.045; and OR 2.893, p = 0.042, respectively). Suprasellar adenomas with extension to adjacent sinuses, although larger than those with only suprasellar extension, did not differ as to the degree of hypopituitarism. Moreover, in suprasellar adenomas, prolactin levels, albeit not independently, were also related to hypopituitarism (OR 1.035, p = 0.045). Conclusions In patients with NFPAs, prognostic factors related to increased risk of hypopituitarism are age at diagnosis, size of the adenoma, and most importantly the presence of suprasellar extension. These data accentuate the necessity for surgical decompression in case of suprasellar extension, in order, apart from saving visual acuity, to possibly avoid or reverse hypopituitarism.
引用
收藏
页码:245 / 251
页数:7
相关论文
共 50 条
  • [31] Collision sellar lesions: coexistence of pituitary adenoma and Rathke cleft cyst—a single-center experience
    Annelise de Almeida Verdolin
    Elisa Baranski Lamback
    Nina Ventura
    André Guasti
    Paulo José da Mata Pereira
    Mônica R. Gadelha
    Leila Chimelli
    Endocrine, 2020, 68 : 174 - 181
  • [32] TTF1-positive posterior pituitary tumors: a single-center experience of 10 years
    Lamback, Elisa
    Camacho, Aline Helen da Silva
    Castro Araujo, Anna Clara
    Wildemberg, Luiz Eduardo
    Filho, Ferdinand Duenas Cabrera
    Andreiuolo, Felipe
    Kasuki, Leandro
    Ventura, Nina
    Chimelli, Leila
    Gadelha, Monica R.
    ENDOCRINE, 2025,
  • [33] Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients
    A. L. Pappy
    A. Savinkina
    C. Bicknese
    S. Neill
    N. M. Oyesiku
    A. G. Ioachimescu
    Pituitary, 2019, 22 : 520 - 531
  • [34] Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients
    Pappy, A. L., II
    Savinkina, A.
    Bicknese, C.
    Neill, S.
    Oyesiku, N. M.
    Ioachimescu, A. G.
    PITUITARY, 2019, 22 (05) : 520 - 531
  • [35] Preoperative Elevated Serum Growth Hormone is Preventive of Osteopenia in Postsurgical Patients With Pituitary Somatotroph Adenomas Comparison With Clinically Nonfunctioning Adenomas
    Sasaki, Mitsuyoshi
    Okazaki, Ryo
    Inoue, Daisuke
    Nakashima, Michi
    Ide, Fuyuaki
    Nakaguchi, Hiroshi
    Yamada, Shoko M.
    Hoya, Katsumi
    Murakami, Mineko
    Mizutani, Akiko
    Okinaga, Hiroko
    Matsuno, Akira
    ENDOCRINOLOGIST, 2009, 19 (05): : 208 - 210
  • [36] OUTCOMES OF TRANSSPHENOIDAL SURGERY IN CUSHING DISEASE PATIENTS WITH NEGATIVE PITUITARY MAGNETIC RESONANCE IMAGING FINDINGS: A SINGLE-CENTER EXPERIENCE
    Dai, Congxin
    Liang, Siyu
    Liu, Xiaohai
    Fan, Yanghua
    Bao, Xinjie
    Yao, Yong
    Deng, Kan
    Lu, Lin
    Wang, Renzhi
    Feng, Ming
    ENDOCRINE PRACTICE, 2020, 26 (11) : 1320 - 1330
  • [37] Clinical Characteristics, Diagnosis, and Treatment of Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor (TSH PitNET): A Single-Center Experience
    Heo, Jung
    Suh, Yeon-Lim
    Kim, Se Hoon
    Kong, Doo-Sik
    Nam, Do-Hyun
    Lee, Won-Jae
    Kim, Sung Tae
    Hong, Sang Duk
    Ryu, Sujin
    Lee, You-Bin
    Kim, Gyuri
    Jin, Sang-Man
    Kim, Jae Hyeon
    Hur, Kyu Yeon
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (02) : 387 - 396
  • [38] Pituitary Stalk Morphology as a Predictor of New-Onset Adrenocortical Insufficiency and Arginine Vasopressin Deficiency after Transsphenoidal Resections of Pituitary Macroadenomas: A Retrospective Single-Center Study with a Focus on iMRI
    Becker, Ralf
    Hlavac, Michal
    Etzrodt-Walter, Gwendolin
    Sommer, Fabian
    Wirtz, Christian Rainer
    Schmitz, Bernd
    Pala, Andrej
    CANCERS, 2023, 15 (15)
  • [39] The outcomes of surgical treatment via transsphenoidal approach for patients with nonfunctioning pituitary adenoma: a single institution's experience
    Choo, Yoon-Hee
    Seo, Youngbeom
    Kim, Oh-Lyong
    ANNALS OF MEDICINE, 2022, 54 (01) : 3136 - 3145
  • [40] Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma A Single-Center, Open-Label, 2-Year Randomized Clinical Trial
    Batista, Rafael L.
    Musolino, Nina R. C.
    Cescato, Valter A. S.
    da Silva, Gilberto O.
    Medeiros, Raphael S. S.
    Herkenhoff, Clarissa G. B.
    Trarbach, Ericka B.
    Cunha-Neto, Malebranche B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (02): : 221 - 227